Central Nervous System Agents in Medicinal Chemistry
Title:Acknowledgements to Reviewers:
Volume: 15 Issue: 2
Export Options
About this article
Cite this article as:
Acknowledgements to Reviewers:, Central Nervous System Agents in Medicinal Chemistry 2015; 15 (2) . https://dx.doi.org/10.2174/187152491502150525121345
DOI https://dx.doi.org/10.2174/187152491502150525121345 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Amyloid Beta Protein as a Marker or Risk Factor of Alzheimers Disease
Current Alzheimer Research Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed
Current Medicinal Chemistry Functional Interference of Dexamethasone on Some Morphine Effects:Hypothesis for the Steroid-Opioid Interaction
Recent Patents on CNS Drug Discovery (Discontinued) Types of Voltage-Gated Calcium Channels: Molecular and Electrophysiological Views
Current Hypertension Reviews Common Genetic Conditions of Ischemic Stroke to Keep in Mind
Current Molecular Medicine The Surgical Management of Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Glutamate and Psychosis Risk
Current Pharmaceutical Design Neuromuscular Blockade in the Optimal Management of Mechanical Ventilation of Patients with Respiratory Distress
Current Respiratory Medicine Reviews Brain Network Connectivity Mediates Education-related Cognitive Performance in Healthy Elderly Adults
Current Alzheimer Research Proton Magnetic Resonance Spectroscopy Changes After Antipsychotic Treatment
Current Medicinal Chemistry Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients
Current Neurovascular Research Proteasome Regulators: Activators and Inhibitors
Current Medicinal Chemistry Integrative Neurochemistry and Neurobiology of Social Recognition and Behavior Analyzed with Respect to CD38-Dependent Brain Oxytocin Secretion
Current Topics in Medicinal Chemistry Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Biologically Active Agents
Current Medicinal Chemistry Synthesis and Structure-Activity Relationship Studies of <i>N</i>-monosubstituted Aroylthioureas as Urease Inhibitors
Medicinal Chemistry Applied Proteomics in Companion Animal Medicine
Current Proteomics Current Strategies and Novel Drug Approaches for Alzheimer Disease
CNS & Neurological Disorders - Drug Targets MoS<sub>2</sub>/Tio<sub>2</sub> Mixture: A Modification Strategies of Tio<sub>2</sub> Nanoparticles to Improve Photocatalytic Activity Under Visible Light
Current Environmental Management (Discontinued) Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Current Drug Metabolism ACE Inhibition Prevents Diastolic Ca2+ Overload and Loss of Myofilament Ca2+ Sensitivity after Myocardial Infarction
Current Molecular Medicine